2020•Frontiers in EndocrinologyOpen access

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF

Raoul Orvieto, Michal Kirshenbaum, Valentina Galiano, T. Elkan Miller, Eran Zilberberg, Jigal Haas, Ravit Nahum

Open full text 13 citations

Abstract

OBJECTIVE: To examine whether the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist protocol may improve conventional IVF/intracytoplasmic sperm injection (ICSI) cycle in poor ovarian response (POR) patients. DESIGN: Cohort historical study. SETTING: Tertiary, University affiliated Medical Center. PATIENT(S): Twenty-three POR patients, defined according to the Bologna criteria, who underwent a subsequent Stop GnRH-agonist combined with multiple-dose GnRH-antagonist controlled ovarian hyperstimulation (COH) protocol, within 3 months of the previous failed conventional IVF/ICSI cycle, were included. For the purposes of this study, we eliminated a bias in this selection by including only "genuine" poor responder patients, defined as those who yielded up to 3 oocytes following COH with a minimal gonadotropin daily dose of 300 IU. MAIN OUTCOME MEASURE(S): Number of oocytes retrieved, number of top-quality embryos, COH variables. RESULT(S): The Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol revealed significantly higher number of follicles >13 mm on the day of hCG administration, higher number of oocytes retrieved and top-quality embryos (TQE), with a reasonable clinical pregnancy rate (13%). Moreover, as expected, patients undergoing the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol required significantly higher doses and longer duration of gonadotropins stimulation. CONCLUSION(S): The combined Stop GnRH-ag/ GnRH-ant COH protocol is a valuable tool in the armamentarium for treating "genuine" poor ovarian responders. Further large prospective studies are needed to elucidate its role in POR and to identify the specific characteristics of women (before initiating ovarian stimulation), that will aid both fertility specialists’ counselling and their patients in adjusting the appropriate COH protocol

Open-access reader

About this research paper

What this paper is about

OBJECTIVE: To examine whether the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist protocol may improve conventional IVF/intracytoplasmic sperm injection (ICSI) cycle in poor ovarian response (POR) patients. DESIGN: Cohort historical study. SETTING: Tertiary, University affiliated Medical Center. PATIENT(S): Twenty-three POR patients, defined according to the Bologna criteria, who underwent a subsequent Stop GnRH-agonist combined with multiple-dose GnRH-antagonist controlled ovarian hyperstimulation (COH) protocol, within 3 months of the previous failed conventional IVF/ICSI cycle, were included. For the purposes of this study, we eliminated a bias in this selection by including only "genuine" poor responder patients, defined as those who yielded up to 3 oocytes following COH with a minimal gonadotropin daily dose of 300 IU. MAIN OUTCOME MEASURE(S): Number of oocytes retrieved, number of top-quality embryos, COH variables. RESULT(S): The Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol revealed significantly higher number of follicles >13 mm on the day of hCG administration, higher number of oocytes retrieved and top-quality embryos (TQE), with a reasonable clinical pregnancy rate (13%). Moreover, as expected, patients undergoing the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol required significantly higher doses and longer duration of gonadotropins stimulation. CONCLUSION(S): The combined Stop GnRH-ag/ GnRH-ant COH protocol is a valuable tool in the armamentarium for treating "genuine" poor ovarian responders. Further large prospective studies are needed to elucidate its role in POR and to identify the specific characteristics of women (before initiating ovarian stimulation), that will aid both fertility specialists’ counselling and their patients in adjusting the appropriate COH protocol

Why it matters

OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To examine whether the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist protocol may improve conventional IVF/intracytoplasmic sperm injection (ICSI) cycle in poor ovarian response (POR) patients. DESIGN: Cohort historical study. SETTING: Tertiary, University affiliated Medical Center. PATIENT(S): Twenty-three POR patients, defined according to the Bologna criteria, who underwent a subsequent Stop GnRH-agonist combined with multiple-dose GnRH-antagonist controlled ovarian hyperstimulation (COH) protocol, within 3 months of the previous failed conventional IVF/ICSI cycle, were included. For the purposes of this study, we eliminated a bias in this selection by including only "genuine" poor responder patients, defined as those who yielded up to 3 oocytes following COH with a minimal gonadotropin daily dose of 300 IU. MAIN OUTCOME MEASURE(S): Number of oocytes retrieved, number of top-quality embryos, COH variables. RESULT(S): The Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol revealed significantly higher number of follicles >13 mm on the day of hCG administration, higher number of oocytes retrieved and top-quality embryos (TQE), with a reasonable clinical pregnancy rate (13%). Moreover, as expected, patients undergoing the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist COH protocol required significantly higher doses and longer duration of gonadotropins stimulation. CONCLUSION(S): The combined Stop GnRH-ag/ GnRH-ant COH protocol is a valuable tool in the armamentarium for treating "genuine" poor ovarian responders. Further large prospective studies are needed to elucidate its role in POR and to identify the specific characteristics of women (before initiating ovarian stimulation), that will aid both fertility specialists’ counselling and their patients in adjusting the appropriate COH protocol

Key concepts: Controlled ovarian hyperstimulation, Agonist, Medicine, Intracytoplasmic sperm injection, Antagonist, Gonadotropin-releasing hormone, Ovarian hyperstimulation syndrome, In vitro fertilisation

Related papers

Back to paper searchBrowse research topicsOriginal source
Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF — Research Paper | ScholarLens